Evogene Market Cap

Evogene has a market cap or net worth of 24.58 million as of April 29, 2026. Its market cap has decreased by -26.55% in one year.

Market Cap

24.58M

Enterprise Value

28.73M

Revenue

12.28M

Ranking

n/a

PE Ratio

n/a

Stock Price

233.00

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 24.58M, a decrease of -78.27%. That is a compound annual growth rate of -7.90%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	28.82M	9.99%
Dec 31, 2025	26.20M	-44.67%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BioLineRx	33.94M
BioLight Life Sciences	22.38M
Can-Fite BioPharma	20.77M
XTL Biopharmaceuticals	18.92M
Purple Biotech	18.59M
Clal Biotechnology Industries	52.70M
Matricelf	81.36M
Geffen Residence & Renewal	270.51M

Market Cap Rankings